HepTcell Immunotherapy in Patients With Inactive Chronic Hepatitis B (CHB)

NCT04684914 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

87

Enrollment

INDUSTRY

Sponsor class

Stopped Did not meet endpoints

Conditions

Hepatitis B, Chronic

Interventions

BIOLOGICAL: HepTcell
DRUG: Placebo

Sponsor

Altimmune, Inc.